Variation in attitudes toward diagnosis and medication of ADHD: a survey among clinicians in the Norwegian child and adolescent mental health services
Tóm tắt
Prevalence and medication rates of ADHD vary geographically, both between and within countries. No absolute cutoff exists between ADHD and normal behavior, making clinician attitudes (leading to local practice cultures) a potential explanation for the observed variation in diagnosis and medication rates. The objective of this study was to describe variation in attitudes toward diagnosis and medication of ADHD among clinicians working in child and adolescent mental health services (CAMHS). We hypothesized that attitudes would vary along a spectrum from “restrictive” to “liberal”. We also explored whether differences in attitudes between clinicians were related to professional background and workplace (clinic). A survey in the form of a web-based questionnaire was developed. All CAMHS outpatient clinics in Norway were invited. Potential respondents were all clinicians involved in diagnosing and treating children and adolescents with ADHD. To investigate the existence of attitudes toward diagnosis and medication as latent constructs, we applied confirmatory factor analysis (CFA). We further examined how much of variance in attitudes could be ascribed to profession and clinics by estimating intraclass correlation coefficients. In total, 674 respondents representing 77 (88%) of the clinics participated. We confirmed variation in attitudes with average responses leaning toward the “restrictive” end of the spectrum. CFA supported “attitude toward diagnosis” and “attitude toward medication” as separate, and moderately correlated (r = 0.4) latent variables, representing a scale from restrictive to liberal. Professional background and workplace explained only a small part of variance in these attitudes.
Tài liệu tham khảo
Mykletun A, Widding-Havneraas T, Chaulagain A, Lyhmann I, Bjelland I, Halmøy A et al (2021) Causal modelling of variation in clinical practice and long-term outcomes of ADHD using Norwegian registry data: the ADHD controversy project. BMJ Open 11(1):e041698
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5™, 5th edn. American Psychiatric Publishing, Inc., Arlington, VA, US
Willcutt EG (2012) The Prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 9(3):490–499
Suren P, Thorstensen AG, Torstad M, Emhjellen PE, Furu K, Biele G et al (2018) Diagnosis of hyperkinetic disorder among children in Norway. Tidsskr for den Norske laegeforen. https://doi.org/10.4045/tidsskr.18.0418
Madsen KB, Ersbøll AK, Olsen J, Parner E, Obel C (2015) Geographic analysis of the variation in the incidence of ADHD in a country with free access to healthcare: a Danish cohort study. Int J Health Geogr 14(1):24
Visser SN, Danielson ML, Bitsko RH, Holbrook JR, Kogan MD, Ghandour RM et al (2014) Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011. J Am Acad Child Adolesc Psychiatry 53(1):34-46.e2
Ørstavik R, Gustavson K, Biele NR-BG, Furu K, Karlstad Ø, Borge TR-KT, et al. (2016) [ADHD in Norway - a status report. Report 2016:4.] The Norwegian Institute of Public Health. ISBN: 978-82-8082-734-0 Norwegian.
Widding-Havneraas T, Markussen S, Elwert F, Lyhmann I, Bjelland I, Halmøy A et al (2022) Geographical variation in ADHD: do diagnoses reflect symptom levels? Eur Child Adolesc Psychiatry. https://doi.org/10.1007/s00787-022-01996-7
Zoëga H, Furu K, Halldórsson M, Thomsen PH, Sourander A, Martikainen JE (2011) Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr Scand 123(5):360–367
Raman SR, Man KKC, Bahmanyar S, Berard A, Bilder S, Boukhris T et al (2018) Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. Lancet Psychiatry 5(10):824–835
Knopf H, Hölling H, Huss M, Schlack R (2012) Prevalence, determinants and spectrum of attention-deficit hyperactivity disorder (ADHD) medication of children and adolescents in Germany: results of the German Health Interview and Examination Survey (KiGGS). BMJ Open 2(6):e000477
Hinshaw SP (2018) Attention Deficit Hyperactivity Disorder (ADHD): Controversy, Developmental Mechanisms, and Multiple Levels of Analysis. Annu Rev Clin Psychol 14:291–316
Parens E, Johnston J (2009) Facts, values, and attention-deficit hyperactivity disorder (ADHD): an update on the controversies. Child Adolesc Psychiatry Ment Health 3:1–17
Bélanger SA, Andrews D, Gray C, Korczak D (2018) ADHD in children and youth: Part 1-Etiology, diagnosis, and comorbidity. Paediatr Child Health 23(7):447–453
Weinberg WA, Emslie GJ (1991) attention deficit hyperactivity disorder the differential diagnosis. J Child Neurol 6(1):S23–S36
Klein B, Damiani-Taraba G, Koster A, Campbell J, Scholz C (2015) Diagnosing attention-deficit hyperactivity disorder (ADHD) in children involved with child protection services: are current diagnostic guidelines acceptable for vulnerable populations? Child Care Health Dev 41(2):178–185
Owens J (2020) Social class, diagnoses of attention-deficit/hyperactivity disorder, and child well-being. J Health Soc Behav 61(2):134–152
O’Connor C, McNicholas F (2020) What differentiates children with ADHD symptoms who do and do not receive a formal diagnosis? Results from a prospective longitudinal cohort study. Child Psychiatry Hum Dev 51(1):138–150
Boland H, DiSalvo M, Fried R, Woodworth KY, Wilens T, Faraone SV et al (2019) A literature review and meta-analysis on the effects of ADHD medications on functional outcomes. J Psychiatr Res 2020(123):21–30
Santos GM, Santos EM, Mendes GD, Fragoso AD, Souza MR, Martimbianco ALC (2021) A review of cochrane reviews on pharmacological treatment for attention deficit hyperactivity disorde. Dementia e Neuropsychologia 15(4):421–427
Jong JDD, Groenewegen PP, Westert GP. Sociological Model for Understanding Medical Practice Variations. In: Johnson A, Stukel TA, editors. Medical Practice Variations. Health Services Research. 1 ed. New York: Springer Science+Business Media; 2016. p. 25–39. https://doi.org/10.1007/978-1-4899-7603-1_159
Adamis D, Tatlow-Golden M, Gavin B, McNicholas F (2019) General practitioners’ (GP) attitudes and knowledge about attention deficit hyperactivity disorder (ADHD) in Ireland. Ir J Med Sci 188(1):231–239
Stockl KM, Hughes TE, Jarrar MA, Secnik K, Perwien AR (2003) Physician perceptions of the use of medications for attention deficit hyperactivity disorder. J Manag Care Pharm 9(5):416–423
Tatlow-Golden M, Prihodova L, Gavin B, Cullen W, McNicholas F (2016) What do general practitioners know about ADHD? Attitudes and knowledge among first-contact gatekeepers: Systematic narrative review. BMC Fam Pract 17(1):1–15
Kovshoff H, Vrijens M, Thompson M, Yardley L, Hodgkins P, Sonuga-Barke EJS et al (2013) What influences clinicians’ decisions about ADHD medication? Initial data from the Influences on Prescribing for ADHD Questionnaire (IPAQ). Eur Child Adolesc Psychiatry 22(9):533–542
Dekkers TJ, Groenman AP, Wessels L, Kovshoff H, Hoekstra PJ, van den Hoofdakker BJ (2021) Which factors determine clinicians’ policy and attitudes towards medication and parent training for children with Attention-Deficit/Hyperactivity Disorder? Eur Child Adolesc Psychiatry. https://doi.org/10.1007/s00787-021-01735-4
Fitzgerald M, McNicholas F (2014) Attitudes and practices in the management of ADHD among healthcare professionals who responded to a European survey. Ir J Psychol Med 31(1):31–37
Acock AC. Assessing goodness of fit. In: Discovering Structural Equation Modeling Using Stata, Revised Edition. Texas: Stata Press; 2013.
Kovshoff H, Williams S, Vrijens M, Danckaerts M, Thompson M, Yardley L et al (2012) The decisions regarding ADHD management (DRAMa) study: Uncertainties and complexities in assessment, diagnosis and treatment, from the clinicians point of view. Eur Child Adolesc Psychiatry 21(2):87–99